Aureka Biotechnologies, Inc.

We’re excited to share that our CEO, Dr. Weian Zhao, will be joining a panel discussion at the 2025 BioPacific Conference in South San Francisco on September 13! Proud to be part of this vibrant gathering of global biotech leaders and innovators, see you there! #BioPacific2025 #AurekaBiotechnologies #Innovation #AIinBiotech #BiotechLeadership #LifeSciences

We’re delighted to welcome Dr. David W. Shen, Founder & CEO of Propeller Bio, to Aureka Biotechnologies, Inc.’ Scientific Advisory Board! Dr. Shen brings a wealth of experience in biopharmaceutical innovation, from scientific research to company building. His leadership and deep expertise will help guide Aureka as we advance our mission to accelerate therapeutic discovery through AI and high-throughput biology. We look forward to working together to push the boundaries of what’s possible in next-generation drug discovery. #AurekaBiotechnologies #ScientificAdvisoryBoard #BiotechInnovation #AIinBiotech #AntibodyDiscovery #DrugDiscovery

We’re excited to announce that Dr. Alon Wellner, VP of Biology at Aureka Biotechnologies, Inc., will be presenting at hubXchange’s Antibody Therapeutics Xchange San Francisco 2025! More details: https://lnkd.in/gkUeiirV Join us as Dr. Wellner shares how we’re integrating cutting-edge AI and high-throughput biology to transform the future of antibody therapeutics. #AntibodyTherapeuticsXchange #BiotechInnovation #AntibodyDiscovery #AurekaBiotechnologies #SanFrancisco2025

We’re excited to share that Dr. Arvin Akoopie, Associate Director at Aureka Biotechnologies, will be presenting at the Antibody Therapeutics Xchange in Boston next Monday! More details: https://lnkd.in/gXbTGPhi He’ll be sharing insights into our cutting-edge approaches to antibody discovery and development. Looking forward to connecting with fellow innovators shaping the future of therapeutics! #hubXchange #AntibodyTherapeuticsXchange #AntibodyDiscovery #BiotechInnovation #AurekaBiotechnologies #BostonEvents

We’re excited to be part of the Carterra 2025 Symposium Series in San Francisco! Our Director of Antibody Discovery, Dr. Xichan(Jack) Hu, will present on “Rapid design of dual-specific antibody therapeutics using AI and high-throughput biology” on Tuesday, June 24th, 2:30–3:00 PM. Looking forward to connecting with fellow innovators pushing the boundaries of antibody engineering! #Carterra2025 #AntibodyDiscovery #SanFrancisco

Excited to share that Aureka Biotechnologies, Inc. will be presenting at the Global Life Science Partnering & Investor Conference! We're eager to showcase our innovations and connect with global industry leaders. Stay tuned for updates! #LifeScience #Innovation #Healthcare #Investors #GlobalConference #AurekaBio #AI #antibody

Exciting Announcement! Dr. Eason Lin, Senior Scientist at Aureka Biotechnologies, Inc., will deliver a keynote at #SLAS2025 International Conference & Exhibition on January 27, 2025, from 11:30 AM to 12:00 PM PST. His talk, “Intelligent and Rapid Discovery of Bispecific and Biparatopic ADCs Using High-Throughput Single-Cell Functional Screening Coupled with Artificial Intelligence De Novo Design Solutions,” will be featured in the Omics and Spatial Omics track. We’re excited for Dr. Lin to share Aureka’s innovations in AI-driven drug discovery! #AurekaBiotech #SLAS2025 #DrugDiscovery #AI #Omics #ADC

Thank you Alliance for Southern California Innovation for your support!

Aureka wishes you a Merry Christmas and a Happy New Year! As we wrap up another incredible year, we want to take a moment to thank our amazing team, partners, and supporters for their hard work and dedication. This holiday season, we celebrate the spirit of collaboration and innovation that drives us forward. Here’s to a joyful holiday filled with peace, laughter, and reflection, and to an even more exciting year ahead! Wishing you all the best for 2025 – let’s make it our brightest year yet!

Aureka Biotechnologies, Inc. is attending the BioLogic Summit 2025! Dr. Alon Wellner, our VP of Biology, will present on “Redefining Therapeutic Possibilities: Aureka’s Integrated AI and High-Throughput Platform for Antibody Innovation”. Dr. Wei Lu, our Senior Director of AI Drug Design, will also share insights on “Design of Multifunctional Antibodies with Generative AI and High-Throughput Data Iteration”. Looking forward to connecting and sharing innovations! #AurekaBiotech #BioLogicSummit #AI #AntibodyInnovation #GenerativeAI